Delivery Order SPE2DB22D1017-SPE2DB24FF4ES
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, with a ceiling value of $13,708.37, is for the delivery of 4,564,148,099 units of the drug Abiraterone Acetate 250 mg tablets in quantities of 120 per bottle. The award has an ultimate completion date of April 3, 2024. This delivery order is part of a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563636913 - Abiraterone Acetate 250 MG Tab 120S. The contract is valued at $1,423.04 and has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not associated with any set-aside designation. The contract is part...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 120 tablets of Abiraterone Acetate 250 mg. The contract has a ceiling value of $33,440.75 and is a Firm Fixed Price Delivery Order with a completion date of June 26, 2025. The contract is not set aside and allows for open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,539.30 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by June 3, 2025. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- This is a $9,372.25 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency for the supply of Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, providing a comprehensive global...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,570,695 units of Abiraterone Acetate 500 mg tablets. The contract has a ceiling value of $14,550.27 and a period of performance through December 2, 2024. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order with a firm fixed price of $1,231.38, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of Abiraterone Acetate 250 mg tablets, with an ultimate completion date of February 21, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Abiraterone Acetate 500 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,334.05 and a period of performance through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,747.20 firm fixed-price contract is for the delivery of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4ESDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,956,809 units of Abiraterone Acetate 250 mg tablets. The $1,742.07 award has a performance period through March 14, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The parent company of AmerisourceBergen Drug Corp is Cencora, Inc., which does business as AmerisourceBergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/13/24 |